The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | COM | 00287Y109 | 782,064 | 14,373,538 | SH | SOLE | 14,373,538 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 677,321 | 20,481,442 | SH | SOLE | 20,481,442 | 0 | 0 | ||
Acceleron Pharma, Inc. | COM | 00434H108 | 716 | 28,765 | SH | SOLE | 28,765 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 576 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 13,820 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 29,078 | 1,096,876 | SH | SOLE | 1,096,876 | 0 | 0 | ||
Adaptimmune Therapeutics plc ADR | SPONDS ADR | 00653A107 | 1,197 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 5,311 | 299,356 | SH | SOLE | 299,356 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 2,468 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 7,059 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 6,330 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Akari Therapeutics PLC ADR | SPONSORED ADR | 00972G108 | 9,499 | 395,882 | SH | SOLE | 395,882 | 0 | 0 | ||
Alcobra Ltd. | SHS | M2239P109 | 9,905 | 1,639,871 | SH | SOLE | 1,639,871 | 0 | 0 | ||
Alder Biopharmaceuticals Inc. | COM | 014339105 | 16,820 | 513,439 | SH | SOLE | 513,439 | 0 | 0 | ||
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 828 | 142,000 | SH | SOLE | 142,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,023,197 | 6,542,599 | SH | SOLE | 6,542,599 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 911 | 11,340 | SH | SOLE | 11,340 | 0 | 0 | ||
Amarin Corporation plc | SPONS ADR NEW | 023111206 | 4,257 | 2,205,710 | SH | SOLE | 2,205,710 | 0 | 0 | ||
Anacor Pharmaceuticals, Inc. | COM | 032420101 | 486,779 | 4,135,412 | SH | SOLE | 4,135,412 | 0 | 0 | ||
Aptose Biosciences, Inc. | COM NEW | 03835T200 | 144 | 33,397 | SH | SOLE | 33,397 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 94,935 | 6,747,332 | SH | SOLE | 6,747,332 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 19,657 | 4,310,666 | SH | SOLE | 4,310,666 | 0 | 0 | ||
Arrowhead Research Corp. | COM NEW | 042797209 | 5,815 | 1,009,509 | SH | SOLE | 1,009,509 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 7,709 | 435,540 | SH | SOLE | 435,540 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 2,390 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
aTyr Pharma Inc. | COM | 002120103 | 23,958 | 2,335,125 | SH | SOLE | 2,335,125 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 1,999 | 711,499 | SH | SOLE | 711,499 | 0 | 0 | ||
Bellerophon Therapeutics, Inc. | COM | 078771102 | 1,832 | 352,928 | SH | SOLE | 352,928 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 60,889 | 4,190,594 | SH | SOLE | 4,190,594 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 160,856 | 14,110,179 | SH | SOLE | 14,110,179 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 1,168 | 210,021 | SH | SOLE | 210,021 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 429,321 | 4,076,353 | SH | SOLE | 4,076,353 | 0 | 0 | ||
BioTime, Inc. Rights | *W EXP 10/01/201 | 09066L162 | 17 | 20,084 | SH | SOLE | 20,084 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 12,072 | 141,105 | SH | SOLE | 141,105 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 22,007 | 7,335,692 | SH | SOLE | 7,335,692 | 0 | 0 | ||
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,318 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 61,532 | 13,553,275 | SH | SOLE | 13,553,275 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 297 | 49,064 | SH | SOLE | 49,064 | 0 | 0 | ||
Chimerix, Inc. | COM | 16934W106 | 4,401 | 115,216 | SH | SOLE | 115,216 | 0 | 0 | ||
Clovis Oncology, Inc. | COM | 189464100 | 18,634 | 202,630 | SH | SOLE | 202,630 | 0 | 0 | ||
Concert Pharmaceuticals, Inc. | COM | 206022105 | 9,308 | 495,908 | SH | SOLE | 495,908 | 0 | 0 | ||
Curis, Inc. | COM | 231269101 | 4,039 | 1,999,303 | SH | SOLE | 1,999,303 | 0 | 0 | ||
Cyclacel Pharmaceuticals, Inc. Pfd. Conv. Ex 6% | PFD CONV EX 6% | 23254L207 | 62 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
CytRx Corporation | COM PAR $.001 | 232828509 | 3,128 | 1,319,989 | SH | SOLE | 1,319,989 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 194,393 | 5,462,019 | SH | SOLE | 2,731,009 | 0 | 0 | ||
Derma Sciences, Inc. | COM PAR $.01 | 249827502 | 16,286 | 3,457,841 | SH | SOLE | 3,457,841 | 0 | 0 | ||
Dermira, Inc. | COM | 24983L104 | 6,419 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Discovery Laboratories, Inc. | COM NEW | 254668403 | 1,071 | 3,569,643 | SH | SOLE | 3,569,643 | 0 | 0 | ||
Dyax Corp. | COM | 26746E103 | 144,349 | 7,561,480 | SH | SOLE | 7,561,480 | 0 | 0 | ||
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,841 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Enanta Pharmaceuticals, Inc. | COM | 29251M106 | 2,723 | 75,357 | SH | SOLE | 75,357 | 0 | 0 | ||
Endocyte, Inc. | COM | 29269A102 | 6,213 | 1,356,552 | SH | SOLE | 1,356,552 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 2,990 | 232,481 | SH | SOLE | 232,481 | 0 | 0 | ||
Five Prime Therapeutics, Inc. | COM | 33830X104 | 296 | 19,247 | SH | SOLE | 19,247 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 15,004 | 2,046,967 | SH | SOLE | 2,046,967 | 0 | 0 | ||
Foundation Medicine, Inc. | COM | 350465100 | 385 | 20,892 | SH | SOLE | 20,892 | 0 | 0 | ||
Galapagos NV ADR | SPON ADR | 36315X101 | 15,033 | 369,276 | SH | SOLE | 369,276 | 0 | 0 | ||
Genomic Health Inc. | COM | 37244C101 | 289,011 | 13,658,328 | SH | SOLE | 13,658,328 | 0 | 0 | ||
Gilead Sciences, Inc. | COM | 375558103 | 24,547 | 249,995 | SH | SOLE | 249,995 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | COM | 37890U108 | 8,432 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 25,934 | 1,931,057 | SH | SOLE | 1,931,057 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 70,950 | 2,907,784 | SH | SOLE | 2,907,784 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 23,370 | 6,976,162 | SH | SOLE | 6,976,162 | 0 | 0 | ||
Ignyta, Inc. | COM | 451731103 | 5,013 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Immune Design Corp. | COM | 45252L103 | 1,817 | 148,937 | SH | SOLE | 148,937 | 0 | 0 | ||
ImmunoGen, Inc. | COM | 45253H101 | 34,061 | 3,548,040 | SH | SOLE | 3,548,040 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,148,673 | 19,474,969 | SH | SOLE | 19,474,969 | 0 | 0 | ||
Insmed, Inc. | COM PAR $.01 | 457669307 | 29,405 | 1,583,490 | SH | SOLE | 1,583,490 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 24,391 | 609,166 | SH | SOLE | 609,166 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 47,327 | 6,554,967 | SH | SOLE | 6,554,967 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | COM CL A | 46333X108 | 1,763 | 169,163 | SH | SOLE | 169,163 | 0 | 0 | ||
Isis Pharmaceuticals, Inc. | COM | 464330109 | 2,310 | 57,140 | SH | SOLE | 57,140 | 0 | 0 | ||
Juno Therapeutics, Inc. | COM | 48205A109 | 3,255 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | COM | 48576U106 | 2,285 | 216,990 | SH | SOLE | 216,990 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 11,450 | 412,008 | SH | SOLE | 412,008 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 6,286 | 73,386 | SH | SOLE | 73,386 | 0 | 0 | ||
Lion Biotechnologies, Inc. | COM | 53619R102 | 10,468 | 1,817,429 | SH | SOLE | 1,817,429 | 0 | 0 | ||
Loxo Oncology, Inc. | COM | 548862101 | 1,748 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 7,449 | 347,776 | SH | SOLE | 347,776 | 0 | 0 | ||
Marinus Pharmaceuticals, Inc. | COM | 56854Q101 | 1,668 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Mast Therapeutics, Inc. | COM | 576314108 | 2,730 | 4,707,464 | SH | SOLE | 4,707,464 | 0 | 0 | ||
Medivation, Inc. | COM | 58501N101 | 28,039 | 659,752 | SH | SOLE | 659,752 | 0 | 0 | ||
MediWound Ltd. | ORD SHS | M68830104 | 1,717 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 101,714 | 2,955,074 | SH | SOLE | 2,955,074 | 0 | 0 | ||
Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | 3,325 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 2,713 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 29,872 | 750,739 | SH | SOLE | 750,739 | 0 | 0 | ||
NeuroDerm Ltd. | ORD SHS | M74231107 | 6,304 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
Novavax, Inc. | COM | 670002104 | 15,524 | 2,195,687 | SH | SOLE | 2,195,687 | 0 | 0 | ||
Ohr Pharmaceuticals, Inc. | COM NEW | 67778H200 | 1,022 | 370,370 | SH | SOLE | 370,370 | 0 | 0 | ||
Omeros Corporation | COM | 682143102 | 3,685 | 336,226 | SH | SOLE | 336,226 | 0 | 0 | ||
Ophthotech Corporation | COM | 683745103 | 1,444 | 35,649 | SH | SOLE | 35,649 | 0 | 0 | ||
Osiris Therapeutics, Inc. | COM | 68827R108 | 9,220 | 499,193 | SH | SOLE | 499,193 | 0 | 0 | ||
Palatin Technologies, Inc. | COM PAR $ .01 | 696077403 | 1,661 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 24,887 | 4,350,808 | SH | SOLE | 4,350,808 | 0 | 0 | ||
Pronai Therapeutics, Inc. | COM | 74346L101 | 4,104 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ProQR Therapeutics N.V. | SHS EURO | N71542109 | 14,400 | 988,299 | SH | SOLE | 988,299 | 0 | 0 | ||
Proteon Therapeutics, Inc. | COM | 74371L109 | 3,820 | 274,617 | SH | SOLE | 274,617 | 0 | 0 | ||
Repros Therapeutics Inc. | COM NEW | 76028H209 | 14,533 | 1,955,944 | SH | SOLE | 1,955,944 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 820 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 4,444 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
Sangamo BioSciences, Inc. | COM | 800677106 | 21,183 | 3,755,876 | SH | SOLE | 3,755,876 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 1,389,307 | 36,029,746 | SH | SOLE | 36,029,746 | 0 | 0 | ||
Seres Therapeutics, Inc. | COM | 81750R102 | 3,705 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 52,679 | 1,262,382 | SH | SOLE | 1,262,382 | 0 | 0 | ||
Stemline Therapeutics, Inc. | COM | 85858C107 | 2,945 | 333,497 | SH | SOLE | 333,497 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM NEW | 867328601 | 2,592 | 3,200,000 | SH | SOLE | 3,200,000 | 0 | 0 | ||
Synergy Pharmaceuticals, Inc. | COM NEW | 871639308 | 356 | 67,100 | SH | SOLE | 67,100 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 1,100 | 180,582 | SH | SOLE | 180,582 | 0 | 0 | ||
Tenax Therapeutics Inc. | COM | 88032L100 | 1,260 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
TG Therapeutics, Inc. | COM | 88322Q108 | 20,200 | 2,003,991 | SH | SOLE | 2,003,991 | 0 | 0 | ||
Threshold Pharmaceuticals, Inc. | COM NEW | 885807206 | 11,907 | 2,925,519 | SH | SOLE | 2,925,519 | 0 | 0 | ||
Trevena, Inc. | COM | 89532E109 | 4,658 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
Trillium Therapeutics, Inc. | COM NEW | 89620X506 | 821 | 63,014 | SH | SOLE | 63,014 | 0 | 0 | ||
Ultragenyx Pharmaceuticals | COM | 90400D108 | 11,932 | 123,894 | SH | SOLE | 123,894 | 0 | 0 | ||
UniQure B.V. | SHS | N90064101 | 614 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Versartis, Inc. | COM | 92529L102 | 37,378 | 3,241,783 | SH | SOLE | 3,241,783 | 0 | 0 | ||
Vitae Pharmaceuticals, Inc. | COM | 92847N103 | 2,065 | 187,597 | SH | SOLE | 187,597 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 10,665 | 872,072 | SH | SOLE | 872,072 | 0 | 0 | ||
XenoPort, Inc. | COM | 98411C100 | 22,585 | 6,508,622 | SH | SOLE | 6,508,622 | 0 | 0 | ||
Zafgen, Inc. | COM | 98885E103 | 12,472 | 390,346 | SH | SOLE | 390,346 | 0 | 0 | ||
Zogenix, Inc. | COM NEW | 98978L204 | 24,278 | 1,798,365 | SH | SOLE | 1,798,365 | 0 | 0 | ||
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | 54,123 | 59,583,000 | PRN | SOLE | 59,583,000 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | CONV BONDS | 00767EAB8 | 19,873 | 26,517,000 | PRN | SOLE | 26,517,000 | 0 | 0 | ||
Array BioPharma Inc. Notes 3.0% 6/1/2020 | CONV BONDS | 04269XAA3 | 2,921 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | 115,619 | 22,379,000 | PRN | SOLE | 22,379,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | 15,899 | 12,228,000 | PRN | SOLE | 12,228,000 | 0 | 0 | ||
Clovis Oncology Inc. 2.5% 9/15/2021 | CONV BONDS | 189464AB6 | 215,311 | 129,300,000 | PRN | SOLE | 129,300,000 | 0 | 0 | ||
Exelisis, Inc. Notes 4.25% 8/15/2019 | CONV BONDS | 30161QAC8 | 23,988 | 20,000,000 | PRN | SOLE | 20,000,000 | 0 | 0 | ||
Gilead, Inc. 1.625% 5/1/16 | CONV BONDS | 375558AP8 | 90,326 | 20,944,000 | PRN | SOLE | 20,944,000 | 0 | 0 | ||
Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | 559,636 | 259,000,000 | PRN | SOLE | 259,000,000 | 0 | 0 | ||
Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | 598,696 | 274,500,000 | PRN | SOLE | 274,500,000 | 0 | 0 | ||
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | CONV BONDS | 74365AAB7 | 2,450 | 3,423,000 | PRN | SOLE | 3,423,000 | 0 | 0 |